Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development

Authors: Joshua M. Donaldson, Marjilla Seddiq, Michael J. Fusco, Shyamli Singla, Gulsum E. Pamuk, Rosa J. Lee-Alonzo, Bronwyn D. Mixter, Kirsten B. Goldberg, Laleh Amiri-Kordestani, R. Angelo de Claro, Nicole Drezner, Nicole J. Gormley, Bindu Kanapuru, Steven J. Lemery, Lola A. Fashoyin-Aje, Nicholas C. Richardson, Harpreet Singh, Daniel L. Suzman, Marc R. Theoret, Paul G. Kluetz, Richard Pazdur

Published: 2023-12-12

DOI: 10.1158/2159-8290.cd-23-1226

Source: Full article

---

Abstract

Summary: